UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Recent Advances in Asymmetric Hydrogenation of Tetrasubstituted Olefins

Journal of the American Chemical Society, 2017-08, Vol.139 (34), p.11630-11641

2017

Volltextzugriff (PDF)

New Horizons in Cancer Treatment: A Closer Look at Novel PI3Kα Inhibitors

ACS medicinal chemistry letters, 2023-09, Vol.14 (9), p.1138-1140

Kargbo, Robert B.

2023

Volltextzugriff (PDF)

Microbiome–Gut–Brain Axis Modulation: New Approaches in Treatment of Neuropsychological and Gastrointestinal Functional Disorders

ACS medicinal chemistry letters, 2023-06, Vol.14 (6), p.692-695

Kargbo, Robert B.

2023

Volltextzugriff (PDF)

Innovative Drug Discovery: Targeting Cancer, Neurological Disorders, and Obesity

ACS medicinal chemistry letters, 2024-09, Vol.15 (9), p.1440-1442

Kargbo, Robert B

2024

Volltextzugriff (PDF)

Emerging Techniques in Cancer Therapy: Precision Targeting for Improved Outcomes

ACS medicinal chemistry letters, 2024-09, Vol.15 (9), p.1446-1448

Kargbo, Robert B

2024

Volltextzugriff (PDF)

Exploring the Therapeutic Potential of Entheogens in Postoperative Cognitive Decline and Psychological Resilience

ACS medicinal chemistry letters, 2024-09, Vol.15 (9), p.1437-1439

Kargbo, Robert B

2024

Volltextzugriff (PDF)

Advancements in Targeted Therapeutics: Integrating Metabolic Modulation, Immune Engineering, and Biologic Formulation Technologies

ACS medicinal chemistry letters, 2024-09, Vol.15 (9), p.1430-1432

Kargbo, Robert B

2024

Volltextzugriff (PDF)

Current Trends in Psychedelic Science: Integrating Modified Lysergic Acid Derivatives and Psilocybin in Modern Medicine

ACS medicinal chemistry letters, 2024-09, Vol.15 (9), p.1443-1445

Kargbo, Robert B

2024

Volltextzugriff (PDF)

New Directions in Antibacterial, Anticancer, and Gene Editing Therapies

ACS medicinal chemistry letters, 2024-09, Vol.15 (9), p.1427-1429

Kargbo, Robert B

2024

Volltextzugriff (PDF)

Psilocybin Therapeutic Research: The Present and Future Paradigm

ACS medicinal chemistry letters, 2020-04, Vol.11 (4), p.399-402

Kargbo, Robert B

2020

Volltextzugriff (PDF)

Treatment of Metabolic Disorders Using Novel DGAT2 Inhibitors: Pyrazolopyridine and Triazolopyridine Derivatives

ACS medicinal chemistry letters, 2024-08, Vol.15 (8), p.1199-1200

Kargbo, Robert B.

2024

Volltextzugriff (PDF)

Innovative Ketamine Formulations: Enhancing Therapeutic Efficacy and Safety

ACS medicinal chemistry letters, 2024-08, Vol.15 (8), p.1188-1190

Kargbo, Robert B.

2024

Volltextzugriff (PDF)

Integrating Neuroprotective and Anti-inflammatory Strategies in the Development of PI3K Inhibitors for Enhanced Cancer Therapy

ACS medicinal chemistry letters, 2024-08, Vol.15 (8), p.1193-1195

Kargbo, Robert B.

2024

Volltextzugriff (PDF)

Innovative Therapeutic Approaches Targeting K‑Ras: Analysis of Macrocyclic Compounds, Peptidomimetics, and Pyridopyrimidine Inhibitors

ACS medicinal chemistry letters, 2024-08, Vol.15 (8), p.1196-1198

Kargbo, Robert B.

2024

Volltextzugriff (PDF)

Transforming Therapeutic Approaches with PROTAC Technology: New Targets and Potentials

ACS medicinal chemistry letters, 2024-05, Vol.15 (5), p.573-575

Kargbo, Robert B.

2024

Volltextzugriff (PDF)

Toward Precision Oncology: The Role of TPD in Targeting CDK2 and Beyond

ACS medicinal chemistry letters, 2024-07, Vol.15 (7), p.1004-1006

Kargbo, Robert B.

2024

Volltextzugriff (PDF)

The New Frontier in Neurotherapeutics: From Brain Stimulation to Novel Psychotropics

ACS medicinal chemistry letters, 2024-07, Vol.15 (7), p.1001-1003

Kargbo, Robert B.

2024

Volltextzugriff (PDF)

Advancements in Protein Degradation for Cancer Therapy

ACS medicinal chemistry letters, 2024-07, Vol.15 (7), p.998-1000

Kargbo, Robert B.

2024

Volltextzugriff (PDF)

Advancing Neurological Therapies: Integrating Novel Compounds and Clinical Trials for Enhanced Cognitive and Neuronal Health

ACS medicinal chemistry letters, 2024-07, Vol.15 (7), p.1007-1009

Kargbo, Robert B.

2024

Volltextzugriff (PDF)

Advances in Targeted Therapies for Inflammatory Diseases and Cancer: Exploring Cellular Mechanisms and Therapeutic Strategies

ACS medicinal chemistry letters, 2024-06, Vol.15 (6), p.758-760

Kargbo, Robert B.

2024

Volltextzugriff (PDF)

Novel Approaches for Upregulation of Tumor Suppressor Proteins: Pioneering Strategies and Integrative Potentials

ACS medicinal chemistry letters, 2024-06, Vol.15 (6), p.761-762

Kargbo, Robert B.

2024

Volltextzugriff (PDF)

Advancements in Psychoactive Alkaloid Delivery, Neuroenhancement, and Psychedelic Therapies: Exploring the Frontiers of Modern Pharmacology

ACS medicinal chemistry letters, 2024-06, Vol.15 (6), p.755-757

Kargbo, Robert B.

2024

Volltextzugriff (PDF)

Lysosomal Degradation of Extracellular Targets: Innovations and Implications

ACS medicinal chemistry letters, 2024-06, Vol.15 (6), p.752-754

Kargbo, Robert B.

2024

Volltextzugriff (PDF)

Neurosteroids and Postpartum Depression: The Mechanism, Efficacy, and Approval of Brexanolone and Zurzuvae

ACS medicinal chemistry letters, 2023-10, Vol.14 (10), p.1326-1328

Kargbo, Robert B.

2023

Volltextzugriff (PDF)

Expanding TPD Horizons: Innovative Strategies Targeting BCL6 and SMARCA2

ACS medicinal chemistry letters, 2024-05, Vol.15 (5), p.576-578

Kargbo, Robert B.

2024

Volltextzugriff (PDF)

1 – 25 von 302

Menü

Weitere Dienste

Einstellungen

Recent Advances in Asymmetric Hydrogenation of Tetrasubstituted Olefins

New Horizons in Cancer Treatment: A Closer Look at Novel PI3Kα Inhibitors

Microbiome–Gut–Brain Axis Modulation: New Approaches in Treatment of Neuropsychological and Gastrointestinal Functional Disorders

Innovative Drug Discovery: Targeting Cancer, Neurological Disorders, and Obesity

Emerging Techniques in Cancer Therapy: Precision Targeting for Improved Outcomes

Exploring the Therapeutic Potential of Entheogens in Postoperative Cognitive Decline and Psychological Resilience

Advancements in Targeted Therapeutics: Integrating Metabolic Modulation, Immune Engineering, and Biologic Formulation Technologies

Current Trends in Psychedelic Science: Integrating Modified Lysergic Acid Derivatives and Psilocybin in Modern Medicine

New Directions in Antibacterial, Anticancer, and Gene Editing Therapies

Psilocybin Therapeutic Research: The Present and Future Paradigm

Treatment of Metabolic Disorders Using Novel DGAT2 Inhibitors: Pyrazolopyridine and Triazolopyridine Derivatives

Innovative Ketamine Formulations: Enhancing Therapeutic Efficacy and Safety

Integrating Neuroprotective and Anti-inflammatory Strategies in the Development of PI3K Inhibitors for Enhanced Cancer Therapy

Innovative Therapeutic Approaches Targeting K‑Ras: Analysis of Macrocyclic Compounds, Peptidomimetics, and Pyridopyrimidine Inhibitors

Transforming Therapeutic Approaches with PROTAC Technology: New Targets and Potentials

Toward Precision Oncology: The Role of TPD in Targeting CDK2 and Beyond

The New Frontier in Neurotherapeutics: From Brain Stimulation to Novel Psychotropics

Advancements in Protein Degradation for Cancer Therapy

Advancing Neurological Therapies: Integrating Novel Compounds and Clinical Trials for Enhanced Cognitive and Neuronal Health

Advances in Targeted Therapies for Inflammatory Diseases and Cancer: Exploring Cellular Mechanisms and Therapeutic Strategies

Novel Approaches for Upregulation of Tumor Suppressor Proteins: Pioneering Strategies and Integrative Potentials

Advancements in Psychoactive Alkaloid Delivery, Neuroenhancement, and Psychedelic Therapies: Exploring the Frontiers of Modern Pharmacology

Lysosomal Degradation of Extracellular Targets: Innovations and Implications

Neurosteroids and Postpartum Depression: The Mechanism, Efficacy, and Approval of Brexanolone and Zurzuvae

Expanding TPD Horizons: Innovative Strategies Targeting BCL6 and SMARCA2

Suchergebnisse filtern